Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study

Mostrar otras versiones (1)

OBJECTIVES: To describe fracture rates, back pain, and health-related quality of life (HRQoL) in postmenopausal women with osteoporosis and prior bisphosphonate therapy, treated with teriparatide for up to 18 months and followed up for a further 18 months. DESIGN: Prospective, multinational, and obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakob, F, Oertel, H, Langdahl, B, Ljunggren, O, Barrett, A, Karras, D, Walsh, J B, Fahrleitner-Pammer, A, Rajzbaum, G, Barker, C, Lems, W F, Marin, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioScientifica 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232638/
https://www.ncbi.nlm.nih.gov/pubmed/22048967
http://dx.doi.org/10.1530/EJE-11-0740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232638/
https://www.ncbi.nlm.nih.gov/pubmed/22048967
http://dx.doi.org/10.1530/EJE-11-0740

Ejemplares similares